COVID-19 Tanılı Hastalarda 30 Gün Sonraki Semptomların İrdelenmesi
- 30 September 2021
- journal article
- research article
- Published by Bilimsel Tip Publishing House in Flora the Journal of Infectious Diseases and Clinical Microbiology
- Vol. 26 (3), 419-425
- https://doi.org/10.5578/flora.20219710
Abstract
Introduction: COVID-19 has wide range of symptoms from mild symptoms to severe respiratory failure. The length of these clinical pictures and the long-term effects of the disease are not yet clear. The aim of this study was to describe symptom characteristics of COVID-19 patients at least 30 days after the date of diagnosis. Materials and Methods: The study included 129 patients who were admitted to our hospital at least 30 days prior to COVID-19 compatible clinical findings and found to be positive for SARS-CoV-2 PCR in nasopharyngeal swab. The patients' presenting symptoms were questioned 30 days after the diagnosis of COVID-19 and their responses were analyzed with a questionnaire conducted at the polyclinic controls or phone call. Results: One hundred and twenty-nine patients with a mean age of 53.8 years were included in our study, with 70 female patients and 59 male patients, and 67 patients had at least one comorbidity. 43% of the patients were hospitalized due to COVID-19 while 7% of the patients were followed in the intensive care unit. The most common symptoms were fatigue (67%), myalgia (65%), back pain (38%), cough (31%) and shortness of breath (26%) respectively. Conclusion: While the primary complaints of the patients, when diagnosed with COVID-19, were seen as respiratory system symptoms; it was observed that the symptoms that continued at least 1 month after the diagnosis were mostly muscle aches and fatigue. The inclusion of outpatients who were discharged within 30 days and the low number of patients with a history of admission to intensive care is considered as a limitation of the study.Keywords
This publication has 13 references indexed in Scilit:
- Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admissionNature Communications, 2020
- Gender, face mask perceptions, and face mask wearing: Are men being dangerous during the COVID-19 pandemic?Personality and Individual Differences, 2020
- COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatryJournal of Affective Disorders, 2020
- Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemicThe Lancet Psychiatry, 2020
- Association Between Hypoxemia and Mortality in Patients With COVID-19Mayo Clinic Proceedings, 2020
- The SARS-CoV-2 outbreak: What we knowInternational Journal of Infectious Diseases, 2020
- Chronic Fatigue Syndrome After COVID-19 Infection: A Call for ActionTurkish Journal of Trauma and Emergency Surgery, 2020
- Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19)World Journal of Emergency Medicine, 2020
- Angiotensin‐converting enzyme 2 deficiency accelerates and angiotensin 1‐7 restores age‐related muscle weakness in miceJournal of Cachexia, Sarcopenia and Muscle, 2018
- Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic ReviewCurrent Neuropharmacology, 2015